Maharashtra, India

Vasudevan Natarajan

This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2017-2022.


% Patents Active = 66.7

 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Vasudevan Natarajan: Innovator in Pharmaceutical Synthesis

Introduction

Vasudevan Natarajan is a prominent inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of processes for the synthesis of ivacaftor. With a total of 3 patents to his name, Natarajan's work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Natarajan's latest patents include a process for the synthesis of ivacaftor, which presents an improved method starting from indole acetic acid ester. This process can be performed in both batch and continuous flow synthesis. Additionally, he has developed a continuous process for synthesizing compounds from a specific formula in a continuous flow reactor. Another notable patent is for a novel one-pot two-step process for synthesizing ivacaftor and related compounds, starting from indole acetic acid amides.

Career Highlights

Natarajan is affiliated with the Council of Scientific and Industrial Research, where he conducts his research and development activities. His innovative approaches to synthesis have garnered attention in the scientific community, showcasing his expertise in the field.

Collaborations

Throughout his career, Natarajan has collaborated with notable colleagues, including Dumbala Srinivasa Reddy and Mrityunjay Keshavprasad Sharma. These collaborations have further enriched his research and contributed to the advancement of pharmaceutical synthesis.

Conclusion

Vasudevan Natarajan is a distinguished inventor whose work in pharmaceutical synthesis is paving the way for advancements in drug development. His innovative processes for synthesizing ivacaftor demonstrate his commitment to improving pharmaceutical methodologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…